Postby zephyr » Wed Mar 20, 2024 8:01 pm
I've had lung mets surgically removed three times. The first two were in Germany because met locations/number made it impossible in the U.S., but the third surgery was here. I've also had multiple rounds of Folfox, Folfiri, plain 5FU, and Xeloda before, after, and between those surgeries, plus a 5-session round of SBRT. All of this over an almost 8-year period. I also had one liver met last year that was treated with ablation, and then a recurrence in my lungs a few months later, followed by chemo. Maybe what the medical team meant but didn't express properly was that if it has now spread to her lungs, that one liver met was not an isolated rogue group of cells and the cancer is more systemic than they thought. Or maybe they were uncertain how well she would respond to more chemo and voiced it with a heavy dose of speculative gloom and doom. Without knowing all the details all I can say is that in my experience, chemo still seems like a possibility. It was for me and I've been on a lot of chemo. Depending on the location of the met, SBRT might be a possibility. Surgery too but sometimes you have to really fight for surgery after a recurrence. Then, as someone else mentioned, perhaps she could find a trial. Maybe she won't get to NED anytime soon, maybe not ever, but that doesn't mean all is lost. Here's a piece of potentially good news: my team told me that the lungs put up a stronger immunological response than the liver. My interpretation of that is that if you have a met that can't or won't be surgically removed, having it in the lung might be preferable because the lungs fight harder.
First things first: are they even certain it's a met and not a benign growth? Has she had a biopsy or a PET scan to check for metabolic activity? Needle biopsies are iffy, better for ruling things in than ruling them out, and with some risk. A PET would tell you if the growth was active. If I had a choice, I'd fight for the PET but that's just me.
I'm not a doctor or healthcare anything, just another patient. I'm not bashing her healthcare providers, just offering views based on my experience but without enough information to know if any of it will apply to your friend. All that being said, I agree with Roadrunner's advice to be careful not to give her false hope by telling her about treatments she can't access.
Nov-2009 Early stage CRC, routine colonoscopy
2010-2014 F/U colonoscopies, all clear
Jun-2016 CRC during F/U colonoscopy, surgery, Stage 4, KRAS, MSS
Aug-2016-May-2018 Folfox, 5FU, Folfiri & Avastin
Aug/Sep-2018 YAG laser surgeries (Germany), 11 nodules removed
Nov-2018 clean CT scan
Mar-2019 New lung nodules
Apr-2019 Dec-2020 Xeloda/Avastin, SBRT, cont. Xeloda/Avastin
Mar-2021 Forfiri/Avastin
Mar-2022 Ablation & Thoracotomy
Feb-2023 Folfiri & Avastin
Nov-2023 Xeloda & Avastin